Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update

Thrombosis and Stroke

2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

Lancet Oncol.

Farge D, Frere C, Connors JM, Ay C, Khorana AA, Munoz A, Brenner B, Kakkar A, Rafii H, Solymoss S, Brilhante D, Monreal M, Bounameaux H, Pabinger I, Douketis J, International Initiative on Thrombosis and Cancer (ITAC) advisory panel.

doi: 10.1016/S1470-2045(19)30336-5.

RECOMMENDED

Thrombosis and Stroke

Apixaban to Prevent Venous Thromboembolism in Patients with Cancer

N Engl J Med.

Carrier M, Abou-Nassar K, Mallick R, Tagalakis V, Shivakumar S, Schattner A, Kuruvilla P, Hill D, Spadafora S, Marquis K, Trinkaus M, Tomiak A, Lee AYY, Gross PL, Lazo-Langner A, El-Maraghi R, Goss G, Le Gal G, Stewart D, Ramsay T, Rodger M, Witham D, Wells PS; AVERT Investigators

doi: 10.1056/NEJMoa1814468.

Thrombosis and Stroke

Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

doi: 10.1056/NEJMoa1711948.

Thrombosis and Stroke

Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer

N Engl J Med.

Agnelli G, Becattini C, Meyer G, Muñoz A, Huisman MV, Connors JM, Cohen A, Bauersachs R, Brenner B, Torbicki A, Sueiro MR, Lambert C, Gussoni G, Campanini M, Fontanella A, Vescovo G, Verso M, Caravaggio Investigators.

doi: 10.1056/NEJMoa1915103.

Cardiovascular Risk and DiseasesHeart Failure

Updated Clinical Practice Guidelines on Heart Failure: An International Alignment

Eur Heart J.

Antman EM, Bax J, Chazal RA, Creager MA, Filippatos G, Halperin JL, Houser S, Lindenfeld J, Pinto FJ, Vardas P, Walsh MN, Williams KA, Zamorano JL

doi: 10.1093/eurheartj/ehw219.

Thrombosis and Stroke

Effect of Low-Intensity vs Standard-Intensity Warfarin Prophylaxis on Venous Thromboembolism or Death Among Patients Undergoing Hip or Knee Arthroplasty: A Randomized Clinical Trial

JAMA.

Gage BF, Bass AR, Lin H, Woller SC, Stevens SM, Al-Hammadi N, Anderson JL, Li J, Rodriguez T Jr, Miller JP, McMillin GA, Pendleton RC, Jaffer AK, King CR, Whipple B, Porche-Sorbet R, Napoli L, Merritt K, Thompson AM, Hyun G, Hollomon W, Barrack RL, Nunley RM, Moskowitz G, Dávila-Román V, Eby CS

doi: 10.1001/jama.2019.12085.

Thrombosis and Stroke

Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy

Cochrane Database Syst Rev

Rutjes AW, Porreca E, Candeloro M, Valeriani E, Di Nisio M

doi: 10.1002/14651858.CD008500.pub5

Thrombosis and Stroke

Effectiveness and safety of apixaban versus rivaroxaban for prevention of recurrent venous thromboembolism and adverse bleeding events in patients with venous thromboembolism: a retrospective population-based cohort analysis

Lancet Haematol.

Dawwas GK, Brown J, Dietrich E, Park H

doi: 10.1016/S2352-

Heart, Artery and Coronary Diseases

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

J Am Coll Cardiol

Writing Committee Members., Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, Evanovich LL, Hung J, Joglar JA, Kantor P, Kimmelstiel C, Kittleson M, Link MS, Maron MS, Martinez MW, Miyake CY, Schaff HV, Semsarian C, Sorajja P

doi: 10.1016/j.jacc.2020.08.044

Related content

2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

Apixaban to Prevent Venous Thromboembolism in Patients with Cancer

Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer

Updated Clinical Practice Guidelines on Heart Failure: An International Alignment

Effect of Low-Intensity vs Standard-Intensity Warfarin Prophylaxis on Venous Thromboembolism or Death Among Patients Undergoing Hip or Knee Arthroplasty: A Randomized Clinical Trial

Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy

Effectiveness and safety of apixaban versus rivaroxaban for prevention of recurrent venous thromboembolism and adverse bleeding events in patients with venous thromboembolism: a retrospective population-based cohort analysis

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines